rdf:type |
|
lifeskim:mentions |
umls-concept:C0008059,
umls-concept:C0024305,
umls-concept:C0205221,
umls-concept:C0205653,
umls-concept:C0332293,
umls-concept:C0443252,
umls-concept:C0684224,
umls-concept:C1274040,
umls-concept:C1456376,
umls-concept:C1516476,
umls-concept:C1707455
|
pubmed:issue |
5
|
pubmed:dateCreated |
2001-12-17
|
pubmed:abstractText |
Early Children's Cancer Group (CCG) trials indicated that the cyclophosphamide, vincristine, methotrexate, and prednisone (COMP) regimen was superior to the LSA2L2 regimen for non-lymphoblastic (NLB) non-Hodgkin lymphoma (NHL). Studies by other groups suggested that addition of anthracyclines to standard therapies could improve outcome. Therefore, in 1983 CCG initiated study CCG-503, a randomized trial of COMP vs. daunomycin-COMP (D-COMP) in children and adolescents with disseminated NLB NHL.
|
pubmed:grant |
http://linkedlifedata.com/resource/pubmed/grant/CA 02649,
http://linkedlifedata.com/resource/pubmed/grant/CA 02971,
http://linkedlifedata.com/resource/pubmed/grant/CA 03526,
http://linkedlifedata.com/resource/pubmed/grant/CA 03750,
http://linkedlifedata.com/resource/pubmed/grant/CA 03888,
http://linkedlifedata.com/resource/pubmed/grant/CA 07306,
http://linkedlifedata.com/resource/pubmed/grant/CA 07431,
http://linkedlifedata.com/resource/pubmed/grant/CA 10382,
http://linkedlifedata.com/resource/pubmed/grant/CA 11796,
http://linkedlifedata.com/resource/pubmed/grant/CA 13539,
http://linkedlifedata.com/resource/pubmed/grant/CA 14560,
http://linkedlifedata.com/resource/pubmed/grant/CA 17829,
http://linkedlifedata.com/resource/pubmed/grant/CA 20320,
http://linkedlifedata.com/resource/pubmed/grant/CA 26044,
http://linkedlifedata.com/resource/pubmed/grant/CA 26126,
http://linkedlifedata.com/resource/pubmed/grant/CA 26270,
http://linkedlifedata.com/resource/pubmed/grant/CA 27678,
http://linkedlifedata.com/resource/pubmed/grant/CA 28851,
http://linkedlifedata.com/resource/pubmed/grant/CA 28882,
http://linkedlifedata.com/resource/pubmed/grant/CA 29013,
http://linkedlifedata.com/resource/pubmed/grant/CA 29314,
http://linkedlifedata.com/resource/pubmed/grant/CA 36004,
http://linkedlifedata.com/resource/pubmed/grant/CA 36015
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0098-1532
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright 2001 Wiley-Liss, Inc.
|
pubmed:issnType |
Print
|
pubmed:volume |
37
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
432-41
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:11745871-Adolescent,
pubmed-meshheading:11745871-Adult,
pubmed-meshheading:11745871-Antibiotics, Antineoplastic,
pubmed-meshheading:11745871-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:11745871-Child,
pubmed-meshheading:11745871-Child, Preschool,
pubmed-meshheading:11745871-Cyclophosphamide,
pubmed-meshheading:11745871-Daunorubicin,
pubmed-meshheading:11745871-Female,
pubmed-meshheading:11745871-Follow-Up Studies,
pubmed-meshheading:11745871-Heart Diseases,
pubmed-meshheading:11745871-Humans,
pubmed-meshheading:11745871-Infant,
pubmed-meshheading:11745871-Infant, Newborn,
pubmed-meshheading:11745871-Infusions, Intravenous,
pubmed-meshheading:11745871-Lymphoma, Non-Hodgkin,
pubmed-meshheading:11745871-Male,
pubmed-meshheading:11745871-Methotrexate,
pubmed-meshheading:11745871-Neutropenia,
pubmed-meshheading:11745871-Prednisone,
pubmed-meshheading:11745871-Recurrence,
pubmed-meshheading:11745871-Stomatitis,
pubmed-meshheading:11745871-Survival Analysis,
pubmed-meshheading:11745871-Thrombocytopenia,
pubmed-meshheading:11745871-Treatment Outcome,
pubmed-meshheading:11745871-Vincristine
|
pubmed:year |
2001
|
pubmed:articleTitle |
Comparison of long-term outcome of children and adolescents with disseminated non-lymphoblastic non-Hodgkin lymphoma treated with COMP or daunomycin-COMP: A report from the Children's Cancer Group.
|
pubmed:affiliation |
Keck School of Medicine, University of Southern California, Los Angeles, California, USA. rsposto@nccf.org
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Randomized Controlled Trial
|